Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs.
Bioorg Med Chem Lett
; 46: 128162, 2021 08 15.
Article
en En
| MEDLINE
| ID: mdl-34062251
ABSTRACT
In the United States, approximately one million individuals are hospitalized every year for arrhythmias, making arrhythmias one of the top causes of healthcare expenditures. Mexiletine is currently used as an antiarrhythmic drug but has limitations. The purpose of this work was to use normal and Long QT syndrome Type 3 (LQTS3) patient-derived human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to identify an analog of mexiletine with superior drug-like properties. Compared to racemic mexiletine, medicinal chemistry optimization of substituted racemic pyridyl phenyl mexiletine analogs resulted in a more potent sodium channel inhibitor with greater selectivity for the sodium over the potassium channel and for late over peak sodium current.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Piridinas
/
Síndrome de QT Prolongado
/
Miocitos Cardíacos
/
Células Madre Pluripotentes Inducidas
/
Canal de Sodio Activado por Voltaje NAV1.5
/
Trastorno del Sistema de Conducción Cardíaco
/
Mexiletine
Límite:
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos